AAAAAA

   
Results: 1-22 |
Results: 22
Immunization of metastatic breast cancer patients with a fully synthetic globe H conjugate: A phase I trial
Authors: Gilewski, T Ragupathi, G Bhuta, S Williams, LJ Musselli, C Zhang, XF Bencsath, KP Panageas, KS Chin, J Hudis, CA Norton, L Houghton, AN Livingston, PO Danishefsky, SJ
Citation: T. Gilewski et al., Immunization of metastatic breast cancer patients with a fully synthetic globe H conjugate: A phase I trial, P NAS US, 98(6), 2001, pp. 3270-3275
Immunization of metastatic breast cancer patients with a fully synthetic Hconjugate: A phase I trial (vol 98, 3270, 2001)
Authors: Gilewski, T Ragupathi, G Bhuta, S Williams, LJ Musselli, C Zhang, XF Bencsath, KP Panageas, KS Chin, J Hudis, CA Norton, L Houghton, AN Livingston, PO Danishefsky, SJ
Citation: T. Gilewski et al., Immunization of metastatic breast cancer patients with a fully synthetic Hconjugate: A phase I trial (vol 98, 3270, 2001), P NAS US, 98(24), 2001, pp. 14186-14186
Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients
Authors: Snijdewint, FGM von Mensdorff-Pouilly, S Karuntu-Wanamarta, AH Verstraeten, AA Livingston, PO Hilgers, J Kenemans, P
Citation: Fgm. Snijdewint et al., Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients, INT J CANC, 93(1), 2001, pp. 97-106
Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21
Authors: Gilewski, T Adluri, S Ragupathi, G Zhang, SL Yao, TJ Panageas, K Moynahan, M Houghton, A Norton, L Livingston, PO
Citation: T. Gilewski et al., Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21, CLIN CANC R, 6(5), 2000, pp. 1693-1701
Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin+QS21 vaccine: A dose-response study
Authors: Chapman, PB Morrissey, DM Panageas, KS Hamilton, WB Zhan, C Destro, AN Williams, L Israel, RJ Livingston, PO
Citation: Pb. Chapman et al., Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin+QS21 vaccine: A dose-response study, CLIN CANC R, 6(3), 2000, pp. 874-879
Vaccination with a bivalent G(M2) and G(D2) ganglioside conjugate vaccine:A trial comparing doses of G(D2)-keyhole limpet hemocyanin
Authors: Chapman, PB Morrisey, D Panageas, KS Williams, L Lewis, JJ Israel, RJ Hamilton, WB Livingston, PO
Citation: Pb. Chapman et al., Vaccination with a bivalent G(M2) and G(D2) ganglioside conjugate vaccine:A trial comparing doses of G(D2)-keyhole limpet hemocyanin, CLIN CANC R, 6(12), 2000, pp. 4658-4662
A second generation synthesis of the MBr1 (Globo-H) breast tumor antigen: New application of the n-pentenyl glycoside method for achieving complex carbohydrate protein linkages
Authors: Allen, JR Allen, JG Zhang, XF Williams, LJ Zatorski, A Ragupathi, G Livingston, PO Danishefsky, SJ
Citation: Jr. Allen et al., A second generation synthesis of the MBr1 (Globo-H) breast tumor antigen: New application of the n-pentenyl glycoside method for achieving complex carbohydrate protein linkages, CHEM-EUR J, 6(8), 2000, pp. 1366-1375
Autoimmune and antitumor consequences of antibodies against antigens shared by normal and malignant tissues
Authors: Livingston, PO Ragupathi, G Musselli, C
Citation: Po. Livingston et al., Autoimmune and antitumor consequences of antibodies against antigens shared by normal and malignant tissues, J CLIN IMM, 20(2), 2000, pp. 85-93
Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates
Authors: Kim, SK Ragupathi, G Cappello, S Kagan, E Livingston, PO
Citation: Sk. Kim et al., Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates, VACCINE, 19(4-5), 2000, pp. 530-537
Polyclonal antibodies from patients immunized with a globe H-keyhole limpet hemocyanin vaccine: Isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens
Authors: Wang, ZG Williams, LJ Zhang, XF Zatorski, A Kudryashov, V Ragupathi, G Spassova, M Bornmann, W Slovin, SF Scher, HI Livingston, PO Lloyd, KO Danishefsky, SJ
Citation: Zg. Wang et al., Polyclonal antibodies from patients immunized with a globe H-keyhole limpet hemocyanin vaccine: Isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens, P NAS US, 97(6), 2000, pp. 2719-2724
Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide
Authors: Lewis, JJ Janetzki, S Schaed, S Panageas, KS Wang, SQ Williams, L Meyers, M Butterworth, L Livingston, PO Chapman, PB Houghton, AN
Citation: Jj. Lewis et al., Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide, INT J CANC, 87(3), 2000, pp. 391-398
Immunization of ovarian cancer patients with a synthetic Lewis(Y)-protein conjugate vaccine: A phase 1 trial
Authors: Sabbatini, PJ Kudryashov, V Ragupathi, G Danishefsky, SJ Livingston, PO Bornmann, W Spassova, M Zatorski, A Spriggs, D Aghajanian, C Soignet, S Peyton, M O'Flaherty, C Curtin, J Lloyd, KO
Citation: Pj. Sabbatini et al., Immunization of ovarian cancer patients with a synthetic Lewis(Y)-protein conjugate vaccine: A phase 1 trial, INT J CANC, 87(1), 2000, pp. 79-85
Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1peptides and N-acetylgalactosamine (GalNAc) peptides
Authors: von Mensdorff-Pouilly, S Petrakou, E Kenemans, P van Uffelen, K Verstraeten, AA Snijdewint, FGM van Kamp, GJ Schol, DJ Reis, CA Price, MR Livingston, PO Hilgers, J
Citation: S. Von Mensdorff-pouilly et al., Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1peptides and N-acetylgalactosamine (GalNAc) peptides, INT J CANC, 86(5), 2000, pp. 702-712
Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21
Authors: Ragupathi, G Meyers, M Adluri, S Howard, L Musselli, C Livingston, PO
Citation: G. Ragupathi et al., Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21, INT J CANC, 85(5), 2000, pp. 659-666
A fully synthetic globo H carbohydrate vaccine induces a focused humoral response in prostate cancer patients: A proof of principle
Authors: Ragupathi, G Slovin, SF Adluri, S Sames, D Kim, IJ Kim, HM Spassova, M Bornmann, WG Lloyd, KO Scher, HI Livingston, PO Danishefsky, SJ
Citation: G. Ragupathi et al., A fully synthetic globo H carbohydrate vaccine induces a focused humoral response in prostate cancer patients: A proof of principle, ANGEW CHEM, 38(4), 1999, pp. 563-566
Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer
Authors: Dickler, MN Ragupathi, G Liu, NX Musselli, C Martino, DJ Miller, VA Kris, MG Brezicka, FT Livingston, PO Grant, SC
Citation: Mn. Dickler et al., Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer, CLIN CANC R, 5(10), 1999, pp. 2773-2779
Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plusBCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodies
Authors: Yao, TJ Meyers, M Livingston, PO Houghton, AN Chapman, PB
Citation: Tj. Yao et al., Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plusBCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodies, CLIN CANC R, 5(1), 1999, pp. 77-81
Immunization of mice with fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells
Authors: Cappello, S Liu, NX Musselli, C Brezicka, FT Livingston, PO Ragupathi, G
Citation: S. Cappello et al., Immunization of mice with fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells, CANCER IMMU, 48(9), 1999, pp. 483-492
Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimalantibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells
Authors: Ragupathi, G Howard, L Cappello, S Koganty, RR Qiu, DX Longenecker, BM Reddish, MA Lloyd, KO Livingston, PO
Citation: G. Ragupathi et al., Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimalantibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells, CANCER IMMU, 48(1), 1999, pp. 1-8
Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugatecancer vaccines
Authors: Kim, SK Ragupathi, G Musselli, C Choi, SJ Park, YS Livingston, PO
Citation: Sk. Kim et al., Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugatecancer vaccines, VACCINE, 18(7-8), 1999, pp. 597-603
Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globoH hexasaccharide conjugate in man
Authors: Slovin, SF Ragupathi, G Adluri, S Ungers, G Terry, K Kim, S Spassova, M Bornmann, WG Fazzari, M Dantis, L Olkiewicz, K Lloyd, KO Livingston, PO Danishefsky, SJ Scher, HI
Citation: Sf. Slovin et al., Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globoH hexasaccharide conjugate in man, P NAS US, 96(10), 1999, pp. 5710-5715
Synthetic and immunological studies on clustered modes of mucin-related Tnand TF O-linked antigens: The preparation of a glycopeptide-based vaccine for clinical trials against prostate cancer
Authors: Kuduk, SD Schwarz, JB Chen, XT Glunz, PW Sames, D Ragupathi, G Livingston, PO Danishefsky, SJ
Citation: Sd. Kuduk et al., Synthetic and immunological studies on clustered modes of mucin-related Tnand TF O-linked antigens: The preparation of a glycopeptide-based vaccine for clinical trials against prostate cancer, J AM CHEM S, 120(48), 1998, pp. 12474-12485
Risultati: 1-22 |